JPH11302158A - Health food having intestinal function controlling action and produced by using enteric seam capsule - Google Patents

Health food having intestinal function controlling action and produced by using enteric seam capsule

Info

Publication number
JPH11302158A
JPH11302158A JP10124156A JP12415698A JPH11302158A JP H11302158 A JPH11302158 A JP H11302158A JP 10124156 A JP10124156 A JP 10124156A JP 12415698 A JP12415698 A JP 12415698A JP H11302158 A JPH11302158 A JP H11302158A
Authority
JP
Japan
Prior art keywords
oil
enteric
health food
intestinal
seam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10124156A
Other languages
Japanese (ja)
Inventor
Shinsuke Kuroiwa
慎介 黒岩
Daigo Fukutake
大吾 福武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORUTO CORP KK
Original Assignee
ORUTO CORP KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORUTO CORP KK filed Critical ORUTO CORP KK
Priority to JP10124156A priority Critical patent/JPH11302158A/en
Publication of JPH11302158A publication Critical patent/JPH11302158A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a health food scarcely affected by gastric acid and water and effectively exhibiting the intestinal function controlling action by encapsulating a specific oil and fat and a specific valuable bacterium in a specific enteric seam capsule. SOLUTION: This health food is produced by encapsulating (A) an oil and fat having intestinal function controlling action, (B) a valuable bacterium having intestinal function controlling action and optionally (C) a water-absorbing substance (e.g. dried starch) in (D) an enteric seam capsule insoluble in gastric acid and soluble in the intestines. The component A is olive oil, palm oil, cottonseed oil, wheat embryo oil, fish oil, etc., the component B is Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium longum, etc., and the component D is e.g. a seam capsule made of gelatin and coated with a component suppressing the solubility in gastric acid (e.g. zein) or a seam capsule composed of gelatin containing sodium alginate.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、腸溶性シームカプ
セルに整腸作用を有する成分を封入した健康食品に関す
る。
TECHNICAL FIELD The present invention relates to a health food in which a component having an intestinal action is encapsulated in an enteric seam capsule.

【0002】[0002]

【従来の技術】従来、整腸作用を目的とする健康食品と
して、アロエ、オリゴ糖、ビフイズス菌、乳酸菌等の顆
粒、錠剤、カプセル形態の製品やオリーブオイル等の食
用油脂が提供されている。
2. Description of the Related Art Conventionally, granules such as aloe, oligosaccharides, bifidobacteria, and lactic acid bacteria, tablets, capsules, and edible oils such as olive oil have been provided as health foods for the purpose of intestinal regulation.

【0003】これら食品のうち、ビフィズス菌、乳酸菌
のような有用細菌は、小腸から大腸に至る腸管で生育
し、生育時の分泌物により腸管のぜん動運動を促進する
ことが知られている。しかし、これらの有用細菌は胃酸
により菌数が減少する。そのため、通常の経口摂取では
その効果が大きく損なわれ、期待したほどの整腸作用が
得られないという欠点がある。一方、胃酸耐性をもつ有
用細菌があれば、効果的な整腸作用をもたらすことにな
ると考えられる。こうした観点から、胃酸耐性有用細菌
の探索が行われているものの、完全な耐性を持ち顕著な
効果を有する有用細菌の発見には至っていないのが実情
である。
[0003] Among these foods, useful bacteria such as bifidobacteria and lactic acid bacteria are known to grow in the intestinal tract from the small intestine to the large intestine, and to promote peristalsis of the intestinal tract by secretions during growth. However, the number of these useful bacteria is reduced by gastric acid. Therefore, there is a drawback that the effect of ordinary oral ingestion is greatly impaired, and the expected intestinal regulation cannot be obtained. On the other hand, if there is a useful bacterium having gastric acid resistance, it is considered that an effective intestinal regulating action will be brought about. From such a viewpoint, a search for useful gastric acid-resistant bacteria has been carried out, but the fact is that useful bacteria having complete resistance and a remarkable effect have not yet been found.

【0004】さらに、これらの有用細菌は水分の存在で
菌数が減少する性質が認められている。有用細菌は顆
粒、錠剤、カプセル等の形態で製品として提供される
が、多くの場合、保存中にこれらの製品は水分を吸収す
るので、その結果有用細菌の数が減少し、大きな整腸効
果が期待できないものとなっている。
[0004] Further, it has been recognized that these useful bacteria have a property of decreasing the number of bacteria in the presence of water. Useful bacteria are provided as products in the form of granules, tablets, capsules, etc., but in many cases these products absorb water during storage, resulting in a decrease in the number of useful bacteria and a large intestinal effect. Is something that cannot be expected.

【0005】また、オリーブオイル等の整腸作用を持つ
油脂は、小腸から大腸にいたる腸管で腸管のぜん動運動
を刺激し、さらに大腸において便の排泄をスムースにす
る潤滑油としての働きを持つことが知られている。
In addition, fats and oils having an intestinal action, such as olive oil, stimulate the peristaltic movement of the intestinal tract in the intestinal tract from the small intestine to the large intestine, and further have a function as a lubricating oil for facilitating excretion of feces in the large intestine. It has been known.

【0006】しかし、これらの油脂は、その90%以上
が体内に吸収され、整腸作用を目的として摂取する場合
は、相当量の油脂の摂取が必要となる。整腸作用のため
のみに大量の油脂を摂取することは、健康面、栄養面か
ら望ましいものではない。必要な量の摂取で、整腸効果
をもたらす摂取方法が求められている。
However, 90% or more of these fats and oils are absorbed into the body, and when ingesting them for the purpose of intestinal regulation, it is necessary to take a considerable amount of fats and oils. Ingesting large amounts of fats and oils solely for the purpose of intestinal regulation is not desirable from a health and nutritional point of view. There is a need for a method of ingesting a necessary amount of the substance to produce an intestinal effect.

【0007】[0007]

【発明が解決しようとする課題】本発明は、胃酸や水分
の影響を大きく受けることなく有用細菌に効果的な整腸
作用を行わせる手段、そして、食用油脂の少量摂取で効
果的な整腸作用を得る手段を提供するものである。本発
明者等は、有用細菌或いは有用油脂を封入する手段につ
き鋭意研究し、特に、腸溶性シームカプセルに注目し、
本発明を完成させたのである。
DISCLOSURE OF THE INVENTION The present invention is directed to a means for causing useful bacteria to perform an effective intestinal action without being significantly affected by stomach acid and water, and an effective intestinal action by ingesting a small amount of edible oils and fats. It is intended to provide a means for obtaining an effect. The present inventors have intensively studied means for encapsulating useful bacteria or useful oils and fats, and particularly focused on enteric seam capsules,
The present invention has been completed.

【0008】[0008]

【課題を解決するための手段】本発明の要旨は、胃酸で
溶解せずに腸管で溶解する腸溶性シームカプセルに、整
腸作用を持つ油脂及び整腸作用を有する有用細菌を封入
したことを特徴とする、健康食品であり、胃酸で溶解せ
ずに腸管で溶解する腸溶性シームカプセルに、整腸作用
を持つ油脂、整腸作用を有する有用細菌及び水分吸収性
物質を封入したことを特徴とする、健康食品である。
The gist of the present invention is to provide an enteric seam capsule which does not dissolve in the stomach acid but dissolves in the intestinal tract, and encloses fats and oils having an intestinal action and useful bacteria having an intestinal action. It is a health food characterized by encapsulating oils and fats having intestinal action, useful bacteria having intestinal action, and a water-absorbing substance in an enteric seam capsule that dissolves in the intestinal tract without dissolving in gastric acid. It is a health food.

【0009】腸溶性シームカプセルとして、ゼラチンか
らなるシームカプセルに胃酸での溶解性を抑制する成分
をコーティングしたもの、或いは、アルギン酸ナトリウ
ムを含むゼラチンからなるシームカプセルを使用するこ
とができる。この際、シームカプセルにコーティングす
る物質としては、ツェイン及びアルギン酸ナトリウムを
使用することができる。
As the enteric seam capsule, a seam capsule made of gelatin coated with a component that inhibits solubility in gastric acid, or a seam capsule made of gelatin containing sodium alginate can be used. At this time, zein and sodium alginate may be used as the material to be coated on the seam capsule.

【0010】また、整腸作用を有する油脂として、オリ
ーブオイル、パーム油、綿実油、小麦胚芽油、大豆油、
やし油、コーン油、ベニバナ油及び魚油からなる群から
選択される少なくとも一種を使用することができ、整腸
作用を有する有用細菌として、Lactobacillus acidophi
lus 、Lactobacillus casei、Lactobacillus bulgaricu
s、Lactobacillus lactis 、Bifidobacterium brave及
びBifidobacterium longum からなる群から選択される
少なくとも一種を使用することができ、更に、水分吸収
性物質として乾燥でんぷんを使用することができる。
[0010] Also, oils and fats having an intestinal action include olive oil, palm oil, cottonseed oil, wheat germ oil, soybean oil,
Palm oil, corn oil, at least one selected from the group consisting of safflower oil and fish oil can be used, and as a useful bacterium having an intestinal action, Lactobacillus acidophi
lus, Lactobacillus casei, Lactobacillus bulgaricu
At least one selected from the group consisting of s, Lactobacillus lactis, Bifidobacterium brave and Bifidobacterium longum can be used, and dried starch can be used as a water-absorbing substance.

【0011】整腸作用を有する食用油脂や有用細菌等
を、胃では溶解せずに腸に至ってはじめて溶解するよう
な容器に封入してやれば、油脂は少量の摂取で、また、
有用細菌に於いては胃でその菌数が減少することなく、
腸で有効に整腸作用を行わせることができる。本発明
は、この原理に則ってなされたものである。即ち、胃酸
では溶解せずに腸で溶解する腸溶性シームカプセルに、
整腸作用を有する食用油脂や有用細菌を封入することに
より、整腸作用を効果的に行わせるものである。
If edible oils and fats or useful bacteria having an intestinal action are sealed in a container which does not dissolve in the stomach but dissolves only in the intestine, the oils and fats can be consumed in a small amount,
For useful bacteria, the number of bacteria in the stomach does not decrease,
Intestinal rectification can be effectively performed in the intestine. The present invention has been made based on this principle. In other words, in an enteric seam capsule that dissolves in the intestine without dissolving in stomach acid,
By enclosing edible oils and fats and useful bacteria having an intestinal action, the intestine action is effectively performed.

【0012】有用細菌を使用する場合には、一日生菌で
50万から100億の菌数を摂取することが望ましいと
される。しかし胃酸により、菌株等によって差がある
が、一般に、大部分の有用細菌は胃酸により死滅してし
まう。有用細菌は腸管内で増殖する為、摂取菌数のうち
一部でも生存していれば効果はあると考えられるが、他
の細菌類と絶えず競争関係にある腸管内の環境では、で
きる限り腸管に届く有用細菌の菌数を増やすことが求め
られる。腸溶性シームカプセルの使用で、有用細菌の菌
数を減少させることなく、有効に働かせることが可能に
なる。
When useful bacteria are used, it is desirable to ingest 500,000 to 10 billion bacteria per day. However, most useful bacteria are generally killed by stomach acid, although there are differences depending on the strain and the like. Since useful bacteria grow in the intestinal tract, it is considered effective if some of the number of ingested bacteria survives.However, in an intestinal environment where there is a constant competition with other bacteria, intestinal tracts should be used as much as possible. It is required to increase the number of useful bacteria that reach the plant. The use of enteric seam capsules allows them to work effectively without reducing the number of useful bacteria.

【0013】腸溶性シームカプセルには、整腸作用を有
する食用油脂と有用細菌とを組み合わせて充填封入す
る。更に、この整腸作用を有する食用油脂と有用細菌に
加えて、水分吸収性の物質を組み合わせて充填封入する
ものである。
An enteric seam capsule is filled and encapsulated by combining an edible oil / fat having an intestinal action and useful bacteria. Furthermore, in addition to the edible oil and fat having an intestinal action and useful bacteria, a water-absorbing substance is combined and filled and sealed.

【0014】腸溶性シームカプセルは、通常のゼラチン
シームカプセル皮膜表面に胃酸での溶解性を抑制する成
分をコーティングする方法、或いはシームカプセル皮膜
そのものを胃酸で溶解しにくい物質で製造することによ
り得られる。シームカプセル皮膜表面にコーティングす
る物質として、ツェインやアルギン酸ナトリウムを使用
することができる。具体的には、ゼラチンで得られたシ
ームカプセルの表面に、ツェイン、アルギン酸ナトリウ
ム等の水溶液を塗布することによって、耐胃酸性のシー
ムカプセルを得ることができる。コーティングに際し
て、ツェイン単独、アルギン酸ナトリウム単独で使用し
ても良いが、両者を併用しても良い。また、アルギン酸
ナトリウムを含むゼラチンから得られるシームカプセル
も、同様に耐胃酸性のシームカプセルとして使用するこ
とができる。
The enteric seam capsule can be obtained by coating the surface of a normal gelatin seam capsule coating with a component that inhibits solubility in stomach acid, or by manufacturing the seam capsule coating itself with a substance that is difficult to dissolve in stomach acid. . Zein or sodium alginate can be used as a substance to be coated on the surface of the seam capsule film. Specifically, a gastric acid-resistant seam capsule can be obtained by applying an aqueous solution of zein, sodium alginate, or the like to the surface of a seam capsule obtained from gelatin. In coating, zein alone or sodium alginate alone may be used, or both may be used in combination. A seam capsule obtained from gelatin containing sodium alginate can also be used as a gastric acid-resistant seam capsule.

【0015】整腸作用を有する有用細菌としては、乳酸
菌(Lactobacillus acidophilus 、Lactobacillus case
i、Lactobacillus bulgaricus、Lactobacillus lactis
等)、 ビフイズス菌(Bifidobacterium brave、Bifido
bacterium longum 等)の菌を用いることができる。
Useful bacteria having an intestinal action include lactic acid bacteria (Lactobacillus acidophilus, Lactobacillus case).
i, Lactobacillus bulgaricus, Lactobacillus lactis
Etc.), Bifidobacterium (Bifidobacterium brave, Bifido
bacterium longum).

【0016】整腸作用を有する油脂としては、オリーブ
オイル、パーム油、綿実油、小麦胚芽油、大豆油、やし
油、コーン油、ベニバナ油や魚油等を用いることができ
る。これらの油脂は、胃で胃酸により部分的な消化が行
われ、中和後リパーゼ等の酵素によりさらに消化され、
90%以上が小腸で吸収される。このため主な整腸作用
である大腸内の便への潤滑作用は吸収されなかった少量
の油脂によるものと考えられる。
Olive oil, palm oil, cottonseed oil, wheat germ oil, soybean oil, coconut oil, corn oil, safflower oil, fish oil and the like can be used as the fat and oil having an intestinal action. These fats and oils are partially digested by stomach acid in the stomach, and further neutralized by enzymes such as lipase after neutralization,
Over 90% is absorbed in the small intestine. For this reason, it is considered that the lubricating effect on stool in the large intestine, which is the main intestinal regulating effect, is due to a small amount of unabsorbed fat and oil.

【0017】これに対して、本発明の腸溶性シームカブ
セルの使用により、食用油脂は胃では消化されずに通過
し腸に至るので、少量の摂取で大きな整腸作用効果が期
待できるのである。
On the other hand, the use of the enteric seam cabcell of the present invention allows the edible oil and fat to pass through the stomach without being digested and reach the intestine, so that a large intestinal effect can be expected with a small amount of ingestion.

【0018】カプセル中に充填する油脂に吸水性物質を
混ぜ込むことにより、さらに、カプセル中の水分の有用
細菌数への影響を抑えることができる。これにより、水
分が有用細菌に及ぼす影響を抑えることができる。吸水
性物質としては、具体的には、乾燥でんぷんを使用する
ことができる。
By mixing the water-absorbing substance into the fat or oil to be filled in the capsule, the influence of the water content in the capsule on the number of useful bacteria can be further suppressed. As a result, the effect of water on useful bacteria can be suppressed. As the water-absorbing substance, specifically, dried starch can be used.

【0019】有用細菌、有用油脂の適正使用量は、概ね
次の通りである。腸溶性シームカプセルに、ビフイズス
菌、乳酸菌等の有用細菌を100mg、オリーブオイル
等の油脂を200mg、乾燥でんぷん等の吸湿材を50
mg程度使用するのが望ましい。本発明は、必ずしもこ
の量比に限定されるものではない。
The appropriate amounts of useful bacteria and useful fats and oils are generally as follows. In an enteric seam capsule, 100 mg of useful bacteria such as bifidobacteria and lactic acid bacteria, 200 mg of oil and fat such as olive oil, and 50 moisture absorbing materials such as dried starch are added.
It is desirable to use about mg. The present invention is not necessarily limited to this quantitative ratio.

【0020】[0020]

【実施例】次に、発明の効果を実施例に基づいて説明す
る。
Next, the effects of the present invention will be described based on embodiments.

【0021】[0021]

【実施例1】本発明の整腸作用に対する効果を確認する
ために、試験を行った。 1.試験方法 ボランティアとして参加した9名を対象に、各種検体を
一日一回任意の時間にに摂取し、その効果を、排便回
数、便量、便性状について調べた。この際、排便回数に
ついては個人差があるため、一日あたりではなく、一週
間あたりの排便回数の増減で示した。便量については、
一回あたりの量とした。また、便性状については、色調
か明るくなる(黒茶色が山吹色になる)を改善とし、硬
さについては、やわらかくなる(硬いがやわらかいにな
る)を改善とした。更に、総合的な所見を示した。
Example 1 A test was conducted to confirm the effect of the present invention on intestinal action. 1. Test Method Various subjects were ingested once a day at an arbitrary time for nine volunteers who participated as volunteers, and the effects were examined for the number of defecations, stool volume, and stool properties. At this time, the number of defecations is shown not by the number of days but by the number of defecations per week, because of individual differences. For the amount of stool,
It was the amount per serving. In terms of the stool properties, the color tone and lightness (black brown became bright yellow) were improved, and the hardness was softened (hard but soft) was improved. In addition, he showed comprehensive findings.

【0022】2.検体 5種類の検体を準備した。各検体の簡単な説明とその内
容を以下に示す。 (1)ビフィズス菌とオリーブオイルを腸溶性シームカ
プセルに封入したもの ビフィズス菌菌数 100億 オリーブオイル量 0.6ml 腸溶性加工 有り (2)ビフィズス菌顆粒 ビフィズス菌菌数 100億 オイル量 無し 腸溶性加工 無し (3)ビフィズス菌錠剤 ビフィズス菌菌数 100億 オイル量 無し 腸溶性加工 無し (4)オリーブオイル ビフィズス菌菌数 無し オリーブオイル量 10ml 腸溶性加工 無し (5)オリーブオイルを腸溶性シームカプセルに封入し
たもの ビフィズス菌菌数 無し オリーブオイル量 10ml 腸溶性加工 有り
2. Samples Five types of samples were prepared. A brief description of each sample and its contents are shown below. (1) Bifidobacterium and olive oil encapsulated in an enteric seam capsule Bifidobacterium count 10 billion Olive oil amount 0.6 ml Enteric processing Yes (2) Bifidobacterium granule Bifidobacterium count 10 billion Oil amount None Enteric No processing (3) Bifidobacterium tablets Bifidobacterium count 10 billion Oil amount None Enteric processing None (4) Olive oil Bifidobacterium count None Olive oil amount 10 ml Enteric processing None (5) Olive oil in enteric seam capsule Included Bifidobacterium count None Olive oil 10ml Enteric coating Yes

【0023】3.試験結果 検体(1)についての試験結果を、表1に示した。この
表に於ける、評価点の意味は、表2に示したとおりであ
る。尚、表2の内容は、表3〜表6についても同様であ
る。検体(2)についての試験結果は表3に、検体
(3)についての試験結果は表4に、検体(4)につい
ての試験結果は表5に、検体(5)についての試験結果
は表6に示した。
3. Test results Table 1 shows the test results for the sample (1). The meanings of the evaluation points in this table are as shown in Table 2. The contents of Table 2 are the same for Tables 3 to 6. Table 3 shows the test results for Sample (2), Table 4 shows the test results for Sample (3), Table 5 shows the test results for Sample (4), and Table 6 shows the test results for Sample (5). It was shown to.

【0024】[0024]

【表1】[Table 1]

【0025】[0025]

【表2】[Table 2]

【0026】[0026]

【表3】[Table 3]

【0027】[0027]

【表4】[Table 4]

【0028】[0028]

【表5】[Table 5]

【0029】[0029]

【表6】[Table 6]

【0030】ビフィズス菌単独の場合、その摂取形態が
顆粒(検体2)のときはその整腸効果が若干認められる
が、錠剤(検体3)の時は整腸効果は顕著には認められ
ない。また、オリーブオイル単独の場合、かなり多量の
オリーブオイルを摂取しても、腸溶性シームカプセルの
使用の有る(検体5)無し(検体4)に拘わらず、整腸
効果はほとんど認められない。それに対して、本発明に
よる、有用細菌のビフィズス菌と少量のオリーブオイル
を組み合わせ腸溶性シームカプセルの封入した検体1に
於いて、著しい整腸効果の発現が認められる。
In the case of Bifidobacterium alone, when the ingested form is granules (specimen 2), the intestinal regulation effect is slightly recognized, but when the tablet (specimen 3) is used, the intestinal regulation effect is not remarkably recognized. In addition, in the case of olive oil alone, even if a large amount of olive oil is ingested, almost no intestinal regulation effect is recognized regardless of whether enteric seam capsules are used (sample 5) or not (sample 4). On the other hand, in the specimen 1 according to the present invention, in which the useful bacterium Bifidobacterium and a small amount of olive oil are combined and the enteric seam capsule is encapsulated, a remarkable intestinal regulation effect is observed.

【0031】[0031]

【実施例2】有用細菌生菌数の減少を抑えるため、水分
吸収剤を添加使用する試験を行った。オリーブオイル2
重量部、ビフィズス菌1重量部及び乾燥でんぷん0.5
重量部を混合し、室温に放置し、生菌数の経時変化を観
察した。対照として、乾燥でんぷんを含まない系、即
ち、ビフィズス菌1重量部とオリーブオイル2重量部と
からなる系をについても同時に試験した。試験結果は、
表7に示すように、乾燥でんぷんを含む系は、乾燥でん
ぷんを含まない系に比較して、生菌の減少がかなり抑え
られることがわかる。これは、有用細菌、油脂等を健康
食品として使用する場合、乾燥でんぷんを添加すると、
生菌数の減少が抑制され、整腸効果が改善されることを
示している。
Example 2 In order to suppress the decrease in the number of useful bacteria, a test was conducted in which a water absorbent was used. Olive oil 2
Parts by weight, 1 part by weight of bifidobacteria and 0.5 parts of dried starch
The parts by weight were mixed and allowed to stand at room temperature, and the change over time in the viable cell count was observed. As a control, a system containing no dried starch, that is, a system consisting of 1 part by weight of bifidobacteria and 2 parts by weight of olive oil was simultaneously tested. The test results are
As shown in Table 7, it can be seen that the system containing dried starch significantly reduces the reduction of viable bacteria as compared to the system not containing dried starch. This is because when using useful bacteria, oils and fats as health food, dry starch is added,
This indicates that the decrease in the number of viable bacteria is suppressed and the intestinal control effect is improved.

【0032】[0032]

【表7】[Table 7]

【0033】[0033]

【発明の効果】整腸作用を有する食品油脂、有用細菌、
或いは吸水性物質を、耐胃酸の腸溶解性シームカプセル
に封入したものを、摂取することにより、少量の摂取量
で顕著な整腸効果を発現する。この効果は、従来から知
られている、ビフィズス菌や乳酸菌の顆粒、錠剤やカプ
セルの形態のものに比較し、格段の効果が認められる。
EFFECT OF THE INVENTION Food fats and oils having intestinal action, useful bacteria,
Alternatively, by ingesting a water-absorbing substance encapsulated in a gastric acid-resistant enteric-soluble seam capsule, a remarkable intestinal regulation effect is exhibited with a small amount of intake. This effect is remarkable compared with conventionally known granules, tablets and capsules of bifidobacteria and lactic acid bacteria.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 35/78 A61K 35/78 K C J U ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 35/78 A61K 35/78 K C J U

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】胃酸で溶解せずに腸管で溶解する腸溶性シ
ームカプセルに、整腸作用を持つ油脂及び整腸作用を有
する有用細菌を封入したことを特徴とする、健康食品。
1. A health food comprising an enteric seam capsule which is soluble in the intestinal tract without being dissolved by gastric acid, and in which an oil and fat having an intestinal action and useful bacteria having an intestinal action are encapsulated.
【請求項2】胃酸で溶解せずに腸管で溶解する腸溶性シ
ームカプセルに、整腸作用を有する油脂、整腸作用を有
する有用細菌及び水分吸収性物質を封入したことを特徴
とする、健康食品。
2. An enteric seam capsule which does not dissolve in gastric acid but dissolves in the intestinal tract, and encloses fats and oils having an intestinal action, useful bacteria having an intestinal action, and a water-absorbing substance. Food.
【請求項3】腸溶性シームカプセルが、ゼラチンからな
るシームカプセルに胃酸での溶解性を抑制する成分をコ
ーティングしたものであることを特徴とする、請求項1
又は請求項2に記載の健康食品。
3. The enteric seam capsule according to claim 1, wherein a seam capsule made of gelatin is coated with a component that inhibits solubility in gastric acid.
Or the health food according to claim 2.
【請求項4】腸溶性シームカプセルが、アルギン酸ナト
リウムを含むゼラチンからなるシームカプセルであるこ
とを特徴とする、請求項1又は請求項2に記載の健康食
品。
4. The health food according to claim 1, wherein the enteric seam capsule is a seam capsule made of gelatin containing sodium alginate.
【請求項5】整腸作用を有する油脂が、オリーブオイ
ル、パーム油、綿実油、小麦胚芽油、大豆油、やし油、
コーン油、ベニバナ油及び魚油からなる群から選択され
る少なくとも一種であることを特徴とする、請求項1又
は請求項2に記載の健康食品。
5. The fat or oil having an intestinal action, comprising: olive oil, palm oil, cottonseed oil, wheat germ oil, soybean oil, coconut oil,
The health food according to claim 1 or 2, wherein the health food is at least one selected from the group consisting of corn oil, safflower oil, and fish oil.
【請求項6】整腸作用を有する有用細菌が、Lactobacil
lus acidophilus 、Lactobacilluscasei、Lactobacillu
s bulgaricus、Lactobacillus lactis 、Bifidobacteri
umbrave及びBifidobacterium longum からなる群から選
択される少なくとも一種であることを特徴とする、請求
項1又は請求項2に記載の健康食品。
6. A useful bacterium having an intestinal regulating action is Lactobacil
lus acidophilus, Lactobacilluscasei, Lactobacillu
s bulgaricus, Lactobacillus lactis, Bifidobacteri
The health food according to claim 1 or 2, wherein the health food is at least one selected from the group consisting of umbrave and Bifidobacterium longum.
【請求項7】水分吸収性物質が、乾燥でんぷんであるこ
とを特徴とする、請求項2に記載の健康食品。
7. The health food according to claim 2, wherein the moisture-absorbing substance is dried starch.
【請求項8】シームカプセルにコーティングする胃酸で
の溶解性を抑制する成分が、ツェイン又は/及びアルギ
ン酸ナトリウムであることを特徴とする、請求項3に記
載の腸溶性シームカプセル。
8. The enteric seam capsule according to claim 3, wherein the component for suppressing the solubility in gastric acid coated on the seam capsule is zein or / and sodium alginate.
JP10124156A 1998-04-16 1998-04-16 Health food having intestinal function controlling action and produced by using enteric seam capsule Pending JPH11302158A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10124156A JPH11302158A (en) 1998-04-16 1998-04-16 Health food having intestinal function controlling action and produced by using enteric seam capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10124156A JPH11302158A (en) 1998-04-16 1998-04-16 Health food having intestinal function controlling action and produced by using enteric seam capsule

Publications (1)

Publication Number Publication Date
JPH11302158A true JPH11302158A (en) 1999-11-02

Family

ID=14878335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10124156A Pending JPH11302158A (en) 1998-04-16 1998-04-16 Health food having intestinal function controlling action and produced by using enteric seam capsule

Country Status (1)

Country Link
JP (1) JPH11302158A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001342127A (en) * 2000-06-02 2001-12-11 Nomoto Kikuo Intestinally absorbable antiinflmmatory factor- containing immunological substance and application thereof
JP2004533442A (en) * 2001-05-15 2004-11-04 キボー バイオテック、インク Prebiotic and probiotic compositions and methods of using them in gut-based therapy
JP2005513111A (en) * 2001-12-11 2005-05-12 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Use of microorganisms for the controlled delivery of substances to specific parts of the digestive tract
JP2008109910A (en) * 2006-10-31 2008-05-15 Toshihiro Nomura Enzyme-compounded granule acting in intestine, and enzyme-compounded food using the enzyme-compounded granule
DE102007039772A1 (en) 2007-08-22 2009-02-26 Cavis Microcaps Gmbh Microcapsule and process for its preparation
JP2009196961A (en) * 2008-02-25 2009-09-03 Qualicaps Co Ltd Enteric capsule
WO2009142170A1 (en) * 2008-05-19 2009-11-26 森下仁丹株式会社 Seamless capsule
EP2689674A1 (en) 2012-07-24 2014-01-29 MAP Chile SpA Micro-encapsulated Animal Protein Concentrate
JP2014506463A (en) * 2011-02-09 2014-03-17 ラヴィヴォ・アーベー Synbiotic composition for recovery and reconstitution of intestinal microbiota
JP2016033118A (en) * 2014-07-31 2016-03-10 森永乳業株式会社 Capsules containing bifidobacterium bacteria and production methods thereof
US9456991B2 (en) 2011-12-22 2016-10-04 Erik Baes Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
CN112168802A (en) * 2019-07-02 2021-01-05 深圳奥萨制药有限公司 Capsule for improving intestinal flora of hypertension patient

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001093881A1 (en) * 2000-06-02 2001-12-13 Ortho Corporation Co., Ltd. Immunological substance containing enteroabsorbable anti-inflammatory factor and application thereof
JP2001342127A (en) * 2000-06-02 2001-12-11 Nomoto Kikuo Intestinally absorbable antiinflmmatory factor- containing immunological substance and application thereof
JP4693085B2 (en) * 2001-05-15 2011-06-01 キボー バイオテック、インク Prebiotic and probiotic compositions and methods of using them in intestinal based therapy
JP2004533442A (en) * 2001-05-15 2004-11-04 キボー バイオテック、インク Prebiotic and probiotic compositions and methods of using them in gut-based therapy
JP2005513111A (en) * 2001-12-11 2005-05-12 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム Use of microorganisms for the controlled delivery of substances to specific parts of the digestive tract
JP2008109910A (en) * 2006-10-31 2008-05-15 Toshihiro Nomura Enzyme-compounded granule acting in intestine, and enzyme-compounded food using the enzyme-compounded granule
DE102007039772A1 (en) 2007-08-22 2009-02-26 Cavis Microcaps Gmbh Microcapsule and process for its preparation
JP2009196961A (en) * 2008-02-25 2009-09-03 Qualicaps Co Ltd Enteric capsule
WO2009142170A1 (en) * 2008-05-19 2009-11-26 森下仁丹株式会社 Seamless capsule
JP2014506463A (en) * 2011-02-09 2014-03-17 ラヴィヴォ・アーベー Synbiotic composition for recovery and reconstitution of intestinal microbiota
US9456991B2 (en) 2011-12-22 2016-10-04 Erik Baes Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
EP2689674A1 (en) 2012-07-24 2014-01-29 MAP Chile SpA Micro-encapsulated Animal Protein Concentrate
JP2016033118A (en) * 2014-07-31 2016-03-10 森永乳業株式会社 Capsules containing bifidobacterium bacteria and production methods thereof
CN112168802A (en) * 2019-07-02 2021-01-05 深圳奥萨制药有限公司 Capsule for improving intestinal flora of hypertension patient
CN112168802B (en) * 2019-07-02 2022-10-21 深圳奥萨制药有限公司 Capsule for improving intestinal flora of hypertension patient

Similar Documents

Publication Publication Date Title
JP6416308B2 (en) Use of purified 2'-fucosyl lactose, 3-fucosyl lactose, and lactodifucotetraose as prebiotics
US8722035B2 (en) Formulations including digestive enzymes, polysorbate-based surfactants and probiotics
ES2607988T3 (en) Feline probiotic bifidobacteria
JP5400997B2 (en) Use of a composition comprising minerals and, in some cases, acetic acid producing bacteria and / or butyric acid producing bacteria, to avoid or reduce gas generation in the large intestine of mammals and abdominal symptoms resulting therefrom
CN104758318B (en) A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate
JP2011500821A (en) Probiotic compositions and methods for inducing and assisting weight loss
KR20190015718A (en) Compositions of probiotics and digestive enzymes and methods for their preparation
JP2000509367A (en) Use of lactoperoxidase, peroxide donor and thiocyanate for the manufacture of a medicament for the treatment of Helicobacter pylori infection
JP2011063597A (en) Oxalate-degrading microorganism or oxalate-degrading enzyme for preventing oxalate-related disease
WO2007046441A1 (en) Pet foods
JPH11302158A (en) Health food having intestinal function controlling action and produced by using enteric seam capsule
JP6181153B2 (en) Compositions containing probiotics and bee pollen / clay complexes, methods for their preparation, and use of the compositions in nutrition and therapeutics
AU2002348340B2 (en) Probiotic compositions
JP2009519897A5 (en)
AU2002348340A1 (en) Probiotic compositions
KR102182093B1 (en) Oral composition comprising graviola mixed powder easy to take
JP2005046054A (en) Diet food and pharmaceutical preparation for diet
JP2005112753A (en) Soft capsule having improved bioavailability
KR20080054912A (en) The process of manufacturing fermented soybeans pill
JPH05238945A (en) Intestinal environment-improving agent
CN103783282A (en) Acidifying agent for improving poultry intestinal absorption
Chomová et al. Development and evaluation of a fish feed mixture containing the probiotic Lactiplantibacillus plantarum prepared using an innovative pellet coating method
JP5907796B2 (en) Intestinal environment improving food
RU2225215C2 (en) Application of propionic acid microorganisms for formation of propionic acid and/or propionates in colon intestine
Code Delayed-release, shelf-stable probiotic formula

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081111

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090317